Series A co-led by founding investor M Ventures and new lead investors Hadean Ventures, Sofinnova Partners, and 4BIO Capital with syndicate including ...

Cysteine Targeting Cysteine-targeted covalent modulation is the most well-established strategy for covalent enzyme targeting in drug discovery, widely embraced in medicinal chemistry for its ...